Grade 1 Chondrosarcoma of Bone: A Diagnostic and Treatment Dilemma

Authors: R. Lor Randall MD1 and William Gowski MD1
View More View Less
  • 1 Department of Orthopedics, Huntsman Cancer Institute & Primary Children's Medical Center, University of Utah, Salt Lake City, Utah

Cartilaginous lesions of bone are relatively common and cover a large spectrum from latent enchondroma to aggressive dedifferentiated chondrosarcoma. Differentiating among these lesions, particularly benign enchondroma and low-grade chondrosarcoma, can be challenging. Differentiating involves assimilation and interpretation of clinical, radiographic, and histologic criteria. Molecular techniques to assist in distinguishing among the various subtypes are being developed, but these techniques have not yielded any clinically significant contribution. As a result of an imperfect diagnostic schema, a consensus on treatment algorithms has been elusive. This review highlights the specific clinical, radiographic, and histologic criteria currently used clinically to differentiate between benign enchondroma and low-grade chondrosarcoma. We discuss the promise of emerging molecular technologies. Finally, we provide a review of the available literature on treatment outcomes, along with a discussion of our own particular preferences.

Correspondence: R. Lor Randall, MD, FACS, Sarcoma Services, Huntsman Cancer Institute, 2000 Circle of Hope, Suite 4260, Salt Lake City, UT 84112-5550. E-mail: r.lor.randall@hsc.utah.edu
  • 1

    Enneking WF. Musculoskeletal Tumor Surgery. New York, NY: Churchill Livingstone; 1983.

  • 2

    Lee FY, Mankin HJ, Fondren G et al.. Chondrosarcoma of bone: an assessment of outcome. J Bone Joint Surg Am 1999;81:326328.

  • 3

    Springfield DS, Gebhardt MC, McGuire MH. Chondrosarcoma: a review. Instr Course Lect 1996;45: 417424.

  • 4

    Marcove RC, Stovell PB, Huvos AG et al.. The use of cryosurgery in the treatment of low and medium grade chondrosarcoma. A preliminary report. Clin Orthop 1977;122:147156.

    • Search Google Scholar
    • Export Citation
  • 5

    Reith JD, Horodyski MB, Scarborough MT et al.. Grade 2 chondrosarcoma: stage I or stage II tumor? Clin Orthop 2003;415:4551.

  • 6

    Schiller AL. Diagnosis of borderline cartilage lesions of bone. Semin Diagn Pathol 1985;2:4262.

  • 7

    Enneking WF, Dunham W, Gebhardt MC. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop 1993;286:241246.

    • Search Google Scholar
    • Export Citation
  • 8

    Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, eds. Manual for Staging of Cancer, 4th ed. Philadelphia, PA: JB Lippincott; 1992:131135.

  • 9

    Hermanek P, Sobin LH. TNM classification of malignant tumors. In: International Union Against Cancer, 4th ed, 2nd version. Berlin, Germany: Springer-Verlag; 1992:2528.

    • Search Google Scholar
    • Export Citation
  • 10

    Bjornsson J, McLeod RA, Unni KK et al.. Primary chondrosarcoma of long bones and limb girdles. Cancer 1998;83:21052019.

  • 11

    Murphey MD, Andrews CL, Flemming DJ et al.. From the archives of the AFIP. Primary tumors of the spine: radiologic pathologic correlation. Radiographics 1996;16:11311158.

    • Search Google Scholar
    • Export Citation
  • 12

    Mirra MJ, Gold R, Downs J et al.. A new histologic approach to the differentiation of enchondroma and chondrosarcoma of the bones: a clinicopathologic analysis of 51 cases. Clin Orthop 1985;201:214237.

    • Search Google Scholar
    • Export Citation
  • 13

    Marco RAW, Lane J, Huvos A. Intralesional excision of intramedullary low grade chondrosarcoma of the extremity. Presented at the 67th annual meeting of the American Academy of Orthopaedic Surgeons, Orlando, FL, March 15-19, 2000.

    • Search Google Scholar
    • Export Citation
  • 14

    Marco RAW, Gitelis S, Brebach GT et al.. Cartilage tumors: evaluation and treatment. J Am Acad Orthop Surg 2000;8:292304.

  • 15

    Pritchard DJ, Lunke RJ, Taylor WF et al.. Chondrosarcoma: a clinicopathologic and statistical analysis. Cancer 1980;45:149157.

  • 16

    Unni KK. Dahlin's Bone Tumors: General Aspects and Data on 11,087 Cases, 5th ed. Philadelphia, PA: Lippincott-Raven; 1996.

  • 17

    Colyer RA, Sallay P, Buckwalter K. MRI assessment of chondroid matrix tumors. In: Limb Salvage: Current Trends–Proceedings of the 7th International Symposium. Singapore: International Symposium of Limb Salvage; 1993:8993.

    • Search Google Scholar
    • Export Citation
  • 18

    Geirnaerdt MJ, Hogendoorn PC, Bloem JL et al.. Cartilaginous tumors: fast contrast-enhanced MR imaging. Radiology 2000;214:539546.

  • 19

    Brenner W, Conrad EU, Eary JF et al.. FDG PET imaging for grading and prediction of outcome in chondrosarcoma patients. Eur J Nucl Med Mol Imaging 2004;31:189195.

    • Search Google Scholar
    • Export Citation
  • 20

    Aoki J, Watanabe H, Shinozaki T et al.. FDG-PET in differential diagnosis and grading of chondrosarcomas. J Comput Assist Tomogr 1999;23:603608.

  • 21

    Sanerkin NG. The diagnosis and grading of chondrosarcoma of bone: a combined cytologic and histologic approach. Cancer 1980;45:582594.

    • Search Google Scholar
    • Export Citation
  • 22

    Ranty ML, Quintyn JC, Courville P et al.. The importance of flow cytometry and the cell proliferation index in choroidal melanoma. J Fr Ophtalmol 2003;26:725729.

    • Search Google Scholar
    • Export Citation
  • 23

    Bridge JA. Cytogenetic and molecular cytogenetic techniques in orthopaedic surgery. J Bone Joint Surg Am 1993;75:606614.

  • 24

    Aigner T. Towards a new understanding and classification of chondrogenic neoplasias of the skeleton: biochemistry and cell biology of chondrosarcoma and its variants. Virchows Arch 2002;441:219230.

    • Search Google Scholar
    • Export Citation
  • 25

    Soderstrom M, Bohling T, Ekfors T et al.. Molecular profiling of human chondrosarcomas for matrix production and cancer markers. Int J Cancer 2002;100:144151.

    • Search Google Scholar
    • Export Citation
  • 26

    Sjogren H, Orndal C, Tingby O. Cytogenetic and spectral karyotype analyses of benign and malignant cartilage tumours. Int J Oncol 2004;24:13851391.

    • Search Google Scholar
    • Export Citation
  • 27

    Ohali A, Avigad S, Cohen IJ et al.. Association between telomerase activity and outcome in patients with nonmetastatic Ewing family of tumors. J Clin Oncol 2003;21:38363843.

    • Search Google Scholar
    • Export Citation
  • 28

    Eriksson AI, Schiller A, Mankin HJ. The management of chondrosarcoma of bone. Clin Orthop 1980;153:4466.

  • 29

    Harwood AR, Krajbich JI, Fornasier VL. Radiotherapy of chondrosarcoma of bone. Cancer 1980;45:27692777.

  • 30

    McNaney D, Lindberg RD, Ayala AG et al.. Fifteen year radiotherapy experience with chondrosarcoma of bone. Int J Radiat Oncol Biol Phys 1982;8:187190.

    • Search Google Scholar
    • Export Citation
  • 31

    Bauer HC, Brosjo O, Kreicbergs A et al.. Low risk of recurrence of enchondroma and low-grade chondrosarcoma in extremities: 80 patients followed for 2–25 years. Acta Orthop Scand 1995;66:283288.

    • Search Google Scholar
    • Export Citation
  • 32

    Schreuder HW, Pruszczynski M, Veth RP et al.. Treatment of benign and low-grade malignant intramedullary chondroid tumours with curettage and cryosurgery. Eur J Surg Oncol 1998;24:120126.

    • Search Google Scholar
    • Export Citation
  • 33

    Ozaki T, Lindner N, Hillmann A et al.. Influence of intralesional surgery on treatment outcome of chondrosarcoma. Cancer 1996;77:12921297.

  • 34

    Pring ME, Weber KL, Unni KK et al.. Chondrosarcoma of the pelvis: a review of sixty-four cases. J Bone Joint Surg Am 2001;83:16301642.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 568 197 19
PDF Downloads 478 186 8
EPUB Downloads 0 0 0